Olympus (OTCMKTS:OCPNY) Stock Crosses Below 200 Day Moving Average – Time to Sell?

Shares of Olympus Co. (OTCMKTS:OCPNY) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group raised Olympus to a “buy” rating in a research report on Monday, May 18th. One analyst has rated the stock with a Buy rating, According to MarketBeat, the company presently has an average rating of “Buy”.

Olympus Trading Down 1.4%

The stock’s fifty day simple moving average is $18.00 and its 200-day simple moving average is $18.00. The firm has a market cap of $23.15 billion, a PE ratio of 21.95, a PEG ratio of 1.07 and a beta of 0.70. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.99 and a quick ratio of 1.48.

About Olympus

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.